The Claim
Urinary detection of artificial sweeteners does not differ by menopausal status, indicating similar overall exposure between premenopausal and postmenopausal women; however, the presence of sucralose in urine is associated with breast cancer in premenopausal but not postmenopausal women, suggesting that hormonal status may influence biological susceptibility to this sweetener's health effects.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Women of all menopausal stages seem to be exposed to artificial sweeteners at similar levels, but finding sucralose in urine might be linked to breast cancer only in women who haven't gone through menopause yet — maybe because hormones play a role in how it affects the body.
See the scientific wording
Urinary detection of artificial sweeteners does not vary by menopausal status in terms of overall exposure, but the health implications may differ, as sucralose presence was associated with premenopausal but not postmenopausal breast cancer, suggesting potential biological differences in susceptibility by hormonal status.
What the research says
1 studyStudy: Urinary artificial sweeteners and breast cancer risk in women from the Moli-sani Study
The study found that women who had sucralose in their urine were more likely to develop breast cancer before menopause, but not after, which matches the idea that the body may react differently to sweeteners depending on hormonal stage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.